InflaRx (IFRX) EPS (Basic) (2016 - 2026)

InflaRx's EPS (Basic) history spans 9 years, with the latest figure at -$0.64 for Q1 2026.

  • On a quarterly basis, EPS (Basic) rose 36.96% to -$0.64 in Q1 2026 year-over-year; TTM through Mar 2026 was -$41187.4, a 18.98% decrease, with the full-year FY2025 number at -$0.79, up 5.03% from a year prior.
  • EPS (Basic) hit -$0.64 in Q1 2026 for InflaRx, down from $4.12 in the prior quarter.
  • Over the last five years, EPS (Basic) for IFRX hit a ceiling of $1501.2 in Q2 2022 and a floor of -$2.1 million in Q1 2023.
  • Historically, EPS (Basic) has averaged -$214833.5 across 5 years, with a median of -$1.37 in 2024.
  • Biggest five-year swings in EPS (Basic): plummeted 73906304.0% in 2023 and later surged 453.0% in 2025.
  • Tracing IFRX's EPS (Basic) over 5 years: stood at -$0.17 in 2022, then plummeted by 35.19% to -$0.22 in 2023, then surged by 433.07% to $0.74 in 2024, then surged by 453.0% to $4.12 in 2025, then crashed by 115.65% to -$0.64 in 2026.
  • Business Quant data shows EPS (Basic) for IFRX at -$0.64 in Q1 2026, $4.12 in Q4 2025, and -$1.51 in Q3 2025.